Xeris Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XERS and other ETFs, options, and stocks.About XERS
Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev.
CEOJohn Patrick Shannon
CEOJohn Patrick Shannon
Employees394
Employees394
HeadquartersChicago, Illinois
HeadquartersChicago, Illinois
Founded2005
Founded2005
Employees394
Employees394
XERS Key Statistics
Market cap1.16B
Market cap1.16B
Price-Earnings ratio-67.60
Price-Earnings ratio-67.60
Dividend yield—
Dividend yield—
Average volume2.03M
Average volume2.03M
High today$7.21
High today$7.21
Low today$6.99
Low today$6.99
Open price$7.10
Open price$7.10
Volume1.96M
Volume1.96M
52 Week high$10.08
52 Week high$10.08
52 Week low$3.14
52 Week low$3.14
Stock Snapshot
Xeris Biopharma(XERS) stock is priced at $7.01, giving the company a market capitalization of 1.16B. It carries a P/E multiple of -67.60.
On 2025-12-18, Xeris Biopharma(XERS) stock moved within a range of $6.99 to $7.21. With shares now at $7.01, the stock is trading +0.3% above its intraday low and -2.8% below the session's peak.
Trading volume for Xeris Biopharma(XERS) stock has reached 1.96M, versus its average volume of 2.03M.
The stock's 52-week range extends from a low of $3.14 to a high of $10.08.
The stock's 52-week range extends from a low of $3.14 to a high of $10.08.
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own XERS. This list is generated using Robinhood data, and it’s not a recommendation.